FMOC-ASN(AC3ACNH-BETA-GLC)-OH
|
|
- CAS-Nr.
- 131287-39-3
- Englisch Name:
- FMOC-ASN(AC3ACNH-BETA-GLC)-OH
- Synonyma:
- fmoc-asn(a;GLCNAC L-ASPARAGINE;FMOC-L-ASN(GLCNAC)-OH;Fmoc-L-Asn(GlcNAc4)-OH;Fmoc-Asn(Ac3GlcNAcβ)-OH;FMOC-ASN(GLCNAC(AC)3-B)-OH;Fmoc-ASN(Ac3AcNH-β-GLC)-OH;Fmoc-Asn(GlcNAc(Ac)-β-D)-OH;Fmoc-Asn(β-D-GlcNAc(Ac)3-OH;Fmoc-L-Asn(GlcNAc(Ac)3-b)-OH
- CBNumber:
- CB6197234
- Summenformel:
- C33H37N3O13
- Molgewicht:
- 683.66
- MOL-Datei:
- 131287-39-3.mol
|
FMOC-ASN(AC3ACNH-BETA-GLC)-OH Eigenschaften
- Siedepunkt:
- 934.7±65.0 °C(Predicted)
- Dichte
- 1.41±0.1 g/cm3(Predicted)
- storage temp.
- -15°C
- Löslichkeit
- Soluble in DMSO
- Aggregatzustand
- Solid
- pka
- 3.81±0.10(Predicted)
- Farbe
- White to off-white
Sicherheit
FMOC-ASN(AC3ACNH-BETA-GLC)-OH Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White to off white powder
Verwenden
Fmoc-ASN(Ac3AcNH-β-GLC)-OH is a synthetic Fmoc-protected glycopeptide with enhanced recognition by glycan-?dependent HIV-?1 broadly neutralizing antibodies.
FMOC-ASN(AC3ACNH-BETA-GLC)-OH Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
FMOC-ASN(AC3ACNH-BETA-GLC)-OH Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 73)Lieferanten
131287-39-3()Verwandte Suche:
- FMOC-L-ASN(GLCNAC)-OH
- FMOC-ASN(AC3ACNH-BETA-GLC)-OH
- Na-Fmoc-Ng-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-b-glucopyranosyl)-L-asparagine≥ 95% (HPLC)
- Fmoc-Asn(GlcNAc(Ac)-β-D)-OH
- Fmoc-L-Asn(GlcNAc(Ac)3-beta)-OH
- Fmoc-L-Asn(GlcNAc(Ac)3-b)-OH
- FMOC-ASN(GLCNAC(AC)3-BETA-D)-OH
- FMOC-ASN(GLCNAC(AC)3-B)-OH
- FMOC-ASPARAGINE(GLCNAC(AC)3-BETA-D)-OH
- GLCNAC L-ASPARAGINE
- N-FMOC-N-ALPHA-(2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSYL)-L-ASPARAGINE
- N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-GAMMA-(2-ACETAMIDO-2DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GALACTOPYRANOSYL)-L-ASPARAGIN
- N-ALPHA-FMOC-N-GAMMA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GLUCOPYRANOSYL)-L-ASPARAGINE
- (N-ALPHA-FMOC-N-GAMMA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-GLUCOPYRANOSYL)-L-ASPARAGINE)
- N-ALPHA-FMOC-N-BETA-(3,4,6-TRI-O-ACETYL-2-(ACETYLAMINO)-DEOXY-2-BETA-GLUCOPYRANOSYL)-L-ASPARAGINE
- N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-GAMMA-(2-ACETAMIDE-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GLUCOPYRANOSYL)-L-ASPARAGINE
- N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-BETA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-BETA-D-GLUCOPYRANOSYL)-L-ASPARAGINE
- Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH
- N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-gamma-(2-acetamido-2deoxy-3,4,6-tri-O-acetyl-beta-D-glucopyranosyl)-L-asparagin
- Fmoc-L-Asn(GlcNAc4)-OH
- N-alpha-Fmoc-N-gamma-(2-acetamido-2-deoxy-3,4,6-tr
- N-(9-Fluorenylmethyloxycarbonyl)-N'-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-beta-D-glucopyranosyl)-L-asparagine
- (S)-2-(((9H-fluoren-9-yl)methyl9H-fluoren-9-yl)methoxy)carbonylamino)-4-((2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-ylamino)-4-oxobutanoic acid
- Fmoc-Asn(GlcNAc(Ac)3-β-D)-OH
- 2N-Fmoc-4N-92-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranosyl)-L-asparagine
- FMoc-Asn(GlcNAc(Ac)3-b-D)-OH
- N-a-FMoc-N-g-(2-acetaMido-2-deoxy-3,4,6-tri-O-acetyl-b-D-glucopyranosyl)-L-asparagine
- FMoc-Asn(β-D-GlcNAc(Ac)3)-OH
- Fmoc-L-Asn(β-D-GlcNAc(Ac)3-OH
- Fmoc-Asn(β-D- GlcNHAc(Ac)3)-OH
- Fmoc-Asn(Ac3GlcNAcβ)-OH
- 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy--D-glucopyranosyl-Fmoc-asparagine, 95%
- L-Asparagine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl]-
- Fmoc-L-Asn((Ac)3-beta-D-GlcNAc)-OH >=95% (HPLC)
- Fmoc-Asn(β-D-GlcNAc(Ac)3-OH
- (2S)-4-[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoicaci
- FMOC-ASN(AC3ACNH-BETA-GLC)-OH USP/EP/BP
- (2S)-4-[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid
- Fmoc-Asn(GlcNAc(Ac)?-β-D)-OH
- fmoc-asn(a
- 3-{[4,5-BIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]-3-ACETAMIDOOXAN-2-YL]CARBAMOYL}-2-{[(9H-FLUOREN-9-YLMET
- Fmoc-ASN(Ac3AcNH-β-GLC)-OH
- 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranosyl-Fmoc-asparagine
- Fmoc-L-Asn(2-D-GlcNAc(Ac)3-OH
- Fmoc-L-Asn(β-D-GlcNAc(Ac)3)-OH
- Fmoc-L-Asn((Ac)3-β-D-GlcNAc)-OH
- Fmoc-Asn(b-D-GlcNAc(Ac)3)-OH
- N-(9-Fluorenylmethyloxycarbonyl)-N'-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-beta-D-glucopyranosyl)-L-asparagine
- (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)amino)-4-oxobutanoic acid
- 131287-39-3
- C33H37N3O13
- Glycoamino Acid